Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from The United Laboratories International Holdings ( (HK:3933) ) is now available.
The United Laboratories International Holdings Limited announced that all proposed resolutions at their 2025 Annual General Meeting were approved by shareholders. Key resolutions included the adoption of financial statements, declaration of dividends, re-election of directors, and granting of mandates related to company securities. This successful AGM reflects shareholder confidence and supports the company’s strategic direction.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$15.29 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, primarily engaged in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, catering to various healthcare needs.
Average Trading Volume: 14,171,419
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.11B
For detailed information about 3933 stock, go to TipRanks’ Stock Analysis page.